FDA 483 - WEBER MEDICAL GMBH - November 05, 2018

The provided document is primarily an informational preface regarding an FDA 483 form, indicating that it contains records processed under FOIA request 2018-10345, released on October 19, 2020. It explains that the observations reported on an FDA 483 are made pursuant to Section 704(b) of the Federal Food, Drug and Cosmetic Act. This section mandates that upon inspection, an officer must report any conditions or practices that suggest a product is adulterated or produced under unsanitary conditions. However, the document does not include a specific company name, inspection dates, main violations or issues, or required actions for a particular establishment. It serves as a general explanation of the legal basis and purpose of an FDA 483 report.